At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible.
#DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL
OVERVIEW
• The Jackson Laboratory is an independent, 501(c)3 nonprofit biomedical research institution founded in 1929 in Bar Harbor, Maine.
• Our mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health.
• We are a global team of nearly 3,000 people at 11 locations in Maine, Connecticut, California, New York, and Japan and in remote locations around the world.
• With a 2023 operating budget of $628M, JAX has substantial impact on our local communities.
RESEARCH
• With more than 60 faculty members, our diverse and multidisciplinary research programs include the National Cancer Institute-designated JAX Cancer Center, as well as coordinated research centers focused on addiction, aging, Alzheimer’s and dementias, genomics and computational biology, precision genetics and rare disease.
• JAX has had a National Cancer Institute-designated Cancer Center since 1983, and is one of only seven institutes in the United States that has received this designation for its contributions to basic cancer research.
• Our researchers have made significant contributions to medical progress, including bone marrow and organ transplants, stem cell therapies and in vitro fertilization.
EDUCATION
• We offer comprehensive educational programs for scientists throughout their careers, from high school students and teachers, to researchers at all experience levels, and for clinical providers interested in incorporating genetics and genomics into their practices.
RESOURCES
• Over 2,400 organizations in 68 countries rely on over 13,000 strains of genetically-specialized JAX® Mice and research services in a wide range of therapeutic areas.
• Our Mouse Genome Informatics database is the world’s source for information on mouse genetics and biology.
Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines.
With over 50 years of experience and 600 global clinic beds (including 24 in-hospital), Celerion conducts and analyzes First-in-Human, clinical proof-of-concept, cardiovascular safety (TQT, robust QT), ADME and NDA-enabling clinical pharmacology studies. Celerion provides expertise on modeling and simulation, study design, medical writing (protocols and reports), clinical data sciences, biostatistics, and PK/PD analysis as well as small and large molecule bioanalytical assays through clinical drug development. Regulatory, drug development and program management complement Celerion’s service offerings.
Our operations are strategically located in:
Lincoln, Nebraska (Corporate Headquarters)
Philadelphia, Pennsylvania
Phoenix, Arizona
Belfast, Northern Ireland,UK
Zurich, Switzerland
Vienna, Austria
Richmond, Virginia
Montreal, Quebec, Canada
For more information, visit: www.celerion.com
Get contact details of over 700M profiles across 60M
companies – all with industry-leading accuracy. Sales and Recruiter users, try out our
Email Finder Extension.
Find business and personal emails and mobile phone numbers
with exclusive coverage across niche job titles, industries, and more
for unparalleled targeting. Also
available via our
Contact Data API.